Future Tech: Almost Here, Round-the-corner Future Technology Podcast

Michael D. West, PhD, founder and CEO of AgeX Therapeutics, Inc. (agexinc.com), delivers an insightful overview of the effects of aging and the cellular aging mechanism. Dr. West received his PhD from Baylor College of Medicine with a concentration in the biology of cellular aging. He has spent the better part of his academic and business career focused on the application of developmental biology to various age-related degenerative diseases. Dr. West discusses the premise of his company, AgeX Therapeutics. As he explains, aging is a national and international priority. He explains how the post WWII population surge has made chronic degenerative diseases a major focus. And the goal at AgeX Therapeutics is to develop new and innovative therapies to combat these chronic degenerative diseases. AgeX Therapeutics is interested in the development and commercialization of unique therapeutics that will target human aging issues. Working forward from their current proprietary technologies, such as PureStem® and induc